Hemp-derived Products Testing Agency: Compliance Must be Fulfilled

Market

Mar.05.2023

ACS Laboratories emphasized the need for compliance with regulations governing hemp-derived products.

David, Fort Lauderdale - On the 2nd day of the APE show, 2FIRSTS carried out random interviews to gather insights on hemp products compliance.

One of the interviewees, staff from the compliance testing institute ACS Laboratories, emphasized the need for compliance with regulations governing hemp-derived products. ACS Laboratories ensures that the products they test are legal and safe, which requires the products to contain no more than the legally allowed amount of THC and no heavy metals, pesticides, mycotoxins, pathogenic microbiology, etc. After the testing, their results will be printed on the labeling of the products.

To start a business in Florida, said ACS Laboratories, you need to get a license through the Department of Agriculture (USDA) and make sure you are running everything according to their guidelines. Every state has its own guidelines approved by the USDA.

#Europe #Open system e-cigarettes #United Kingdom #Products #Regulation #Drug testing #Product

*This article is an original article of 2FIRSTS Technology Co., Ltd. The copyright and license rights belong to the company. Any entity or individual shall make link and credit 2FIRSTS when taking actions to copy, reprint or distribute the original article. The company retains the right to pursue its legal responsibility.

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

EVO NXT European Tobacco & NGP Exhibition

EVO NXT European Tobacco & NGP Exhibition

NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift

NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift

According to The New York Times, Reynolds American donated $5 million to a Trump-backed super PAC shortly before the FDA introduced a new policy that could benefit major tobacco companies seeking to sell flavored vaping products.

FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit

FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit

FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.

U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco

U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco

U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.

BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo

BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo

British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.

RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes

RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes

Richard Danker, a senior public affairs official in Health Secretary Robert F. Kennedy Jr.’s team, resigned from his role at HHS over the FDA’s recent authorization of fruit-flavored vaping products. In a resignation letter addressed to President Donald Trump, Danker argued that the products could expose minors to nicotine addiction, lung damage, and increased cancer risks, while also conflicting with recent HHS guidance on youth risks associated with flavored nicotine products.

FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications

FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications

The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.

Related Topics

Related Read

NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift

NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift

FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit

FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit

U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco

U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco

BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo

BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo

RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes

RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes

FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications

FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications